A look at ATTAIN-1 and ATTAIN-2 found similar results before, during and after menopause, with waists shrinking by up to 12.5 cm over 72 weeks.
Recap by typeshit. Full story at Healthline.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
An explainer on how the two weekly injections differ, starting with their separate active ingredients.
TRM says crypto payments to vendors listing both rose 32% to $37.3M in 2025, with US buyers making up about 57% of the payments it could trace to a country.
Loading…